CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 4 Planned sale Director sold 281,541 shares at an average $44.76 ($12,601,536)
- 4 Planned sale Director sold 212,477 shares at an average $42.93 ($9,121,902)
- 4/A Planned sale Director sold 183,834 shares at an average $42.85 ($7,877,091)
- 4 Planned sale Director sold 183,834 shares at an average $42.85 ($7,877,091)
- 4/A Planned sale Chief Operating Officer sold 40,000 shares at an average $35.09 ($1,403,668)
- 4 Planned sale Chief Operating Officer sold 39,950 shares at an average $35.09 ($1,401,902)
- 4 Planned sale Chief Operating Officer sold 40,000 shares at an average $33.36 ($1,334,201)
- 4 Open-market sale Chief Scientific Officer sold 2,136 shares at $31.34 ($66,942)
- 4 Planned sale Chief Medical Officer sold 2,636 shares at $31.27 ($82,428)
- 4 Planned sale Chief Operating Officer sold 85,270 shares at an average $30.30 ($2,583,782)
- 4 Open-market sale Chief Business Officer sold 1,823 shares at $31.34 ($57,133)
- 4 Planned sale SVP, Head of Finance & Admin. sold 2,921 shares at an average $30.74 ($89,779)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Scientific Officer sold 30,426 shares at an average $32.96 ($1,002,751)
- 4 Planned sale Chief Scientific Officer sold 2,705 shares at an average $28.27 ($76,469)
Page 8 of 19 · 361 filings